The molecular relationship between antigenic domains and epitopes on hCG

Molecular Immunology

Volumn 76, Issue , 2016, Pages 134-145

  Berger, Peter ^a   Lapthorn, Adrian J ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Antigenic domains; Harmonizing immunoassays; hCG; Number of epitopes; Pregnancy testing; Variants

Indexed keywords

AMINO ACID DERIVATIVE; CARBOHYDRATE; CHORIONIC GONADOTROPIN; CYTIDINE TRIPHOSPHATE; EPITOPE; LUTEINIZING HORMONE; TUMOR MARKER; ANTIGEN;

ANTIGEN BINDING; ANTIGENICITY; BINDING SITE; CROSS REACTION; GLYCOSYLATION; HUMAN; PREGNANCY; PRIORITY JOURNAL; REVIEW; SPECIES DIFFERENCE; TISSUE DIFFERENTIATION; CHEMISTRY; IMMUNOLOGY; MOLECULAR MODEL; X RAY CRYSTALLOGRAPHY;

ANTIGENS; CHORIONIC GONADOTROPIN; CRYSTALLOGRAPHY, X-RAY; EPITOPES, B-LYMPHOCYTE; HUMANS; MODELS, MOLECULAR;

EID: 84978776433     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2016.06.015     Document Type: Review

References (76)

1. Alfthan, H., Haglund, C., Roberts, P., Stenman, U.H., Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res. 52 (1992), 4628–4633.
2. Berger, P., Sturgeon, C., Human chorionic gonadotropin isoforms and their epitopes: diagnostic utility in pregnancy and cancer. Expert Opin. Med. Diagn. 2 (2008), 1347–1364.
3. Berger, P., Sturgeon, C., Pregnancy testing with hCG–future prospects. Trends Endocrinol. Metab.: TEM 25 (2014), 637–648.
4. Berger, P., Panmoung, W., Khaschabi, D., Mayregger, B., Wick, G., Antigenic features of human follicle stimulating hormone delineated by monoclonal antibodies and construction of an immunoradiomometric assay. Endocrinology 123 (1988), 2351–2359.
5. Berger, P., Schwarz, S., Spottl, G., Wick, G., Mann, K., Variants of human chorionic gonadotropin from pregnant women and tumor patients recognized by monoclonal antibodies. J. Clin. Endocrinol. Metab. 77 (1993), 347–351.
6. Berger, P., Sturgeon, C., Bidart, J.M., Paus, E., Gerth, R., Niang, M., Bristow, A., Birken, S., Stenman, U.H., The ISOBM TD-7 Workshop on hCG and related molecules. Towards user-oriented standardization of pregnancy and tumor diagnosis: assignment of epitopes to the three-dimensional structure of diagnostically and commercially relevant monoclonal antibodies directed against human chorionic gonadotropin and derivatives. Tumor Biol. 23 (2002), 1–38.
7. Berger, P., Gruschwitz, M., Spoettl, G., Dirnhofer, S., Madersbacher, S., Gerth, R., Merz, W.E., Plas, E., Sampson, N., Human chorionic gonadotropin (hCG) in the male reproductive tract. Mol. Cell. Endocrinol. 260–262 (2007), 190–196.
8. Berger, P., [Molecular morphology of placental and pituitary hormones: epitope mapping with monoclonal antibodies]. Wien. Klin. Wochenschr. 97 (1985), 573–581.
9. Bidart, J.M., Troalen, F., Bohuon, C.J., Hennen, G., Bellet, D.H., Immunochemical mapping of a specific domain on human choriogonadotropin using anti-protein and anti-peptide monoclonal antibodies. J. Biol. Chem. 262 (1987), 15483–15489.
10. Bidart, J.M., Troalen, F., Bousfield, G.R., Birken, S., Bellet, D.H., Antigenic determinants on human choriogonadotropin alpha-subunit. I. Characterization of topographic sites recognized by monoclonal antibodies. J. Biol. Chem. 263 (1988), 10364–10369.
11. Bidart, J.M., Birken, S., Berger, P., Krichevsky, A., Immunochemical mapping of hCG and hCG-related molecules. Scand. J. Clin. Lab. Invest. Suppl. 216 (1993), 118–136.
12. Birken, S., Berger, P., Bidart, J.M., Weber, M., Bristow, A., Norman, R., Sturgeon, C., Stenman, U.H., Preparation and characterization of new WHO reference reagents for human chorionic gonadotropin and metabolites. Clin. Chem. 49 (2003), 144–154.
13. Birken, S., Yershova, O., Myers, R.V., Bernard, M.P., Moyle, W., Analysis of human choriogonadotropin core 2 o-glycan isoforms. Mol. Cell. Endocrinol. 204 (2003), 21–30.
14. Bristow, A., Berger, P., Bidart, J.M., Birken, S., Norman, R., Stenman, U.H., Sturgeon, C., Establishment, value assignment, and characterization of new WHO reference reagents for six molecular forms of human chorionic gonadotropin. Clin. Chem. 51 (2005), 177–182.
15. Butler, S.A., Laidler, P., Porter, J.R., Kicman, A.T., Chard, T., Cowan, D.A., Iles, R.K., The beta subunit of human chorionic gonadotropin exists as a homodimer. J. Mol. Endocrinol. 22 (1999), 185–192.
16. Charrel-Dennis, M., Jackson, A.M., Lund, T., Lapthorn, A.J., Berger, P., Roitt, I.M., Delves, P.J., The major hormone-specific discontinuous epitopes on human chorionic gonadotrophin. J. Mol. Endocrinol. 32 (2004), 571–581.
17. Cole, L.A., Birken, S., Sutphen, S., Hussa, R.O., Pattillo, R.A., Absence of the COOH-terminal peptide on ectopic human chorionic gonadotropin beta-subunit (hCG beta). Endocrinology 110 (1982), 2198–2200.
18. Cole, L.A., Antibodies for intact hCG, for total hCG, for free subunits, glycosylation variants, and for hCG fragments. Cole, L.A.A.B., SA, (eds.) Human Chorionic Gonadotropin (hCG), 2010, Elsevier Amsterdam, 221–224.
19. Cunningham, B.C., Wells, J.A., Comparison of a structural and a functional epitope. J Mol Biol 234 (1993), 554–563.
20. de Medeiros, S.F., Norman, R.J., Human choriogonadotrophin protein core and sugar branches heterogeneity: basic and clinical insights. Hum. Reprod. Update 15 (2009), 69–95.
21. Delves, P.J., Iles, R.K., Roitt, I.M., Lund, T., Designing a new generation of anti-hCG vaccines for cancer therapy. Mol. Cell. Endocrinol. 260–262 (2007), 276–281.
22. Dirnhofer, S., Klieber, R., De Leeuw, R., Bidart, J.M., Merz, W.E., Wick, G., Berger, P., Functional and immunological relevance of the COOH-terminal extension of human chorionic gonadotropin beta: implications for the WHO birth control vaccine. FASEB J. 7 (1993), 1381–1385.
23. Dirnhofer, S., Madersbacher, S., Bidart, J.M., Ten Kortenaar, P.B., Spottl, G., Mann, K., Wick, G., Berger, P., The molecular basis for epitopes on the free beta-subunit of human chorionic gonadotrophin (hCG), its carboxyl-terminal peptide and the hCG beta-core fragment. J. Endocrinol. 141 (1994), 153–162.
24. Dirnhofer, S., Lechner, O., Madersbacher, S., Klieber, R., de Leeuw, R., Wick, G., Berger, P., Free alpha subunit of human chorionic gonadotrophin: molecular basis of immunologically and biologically active domains. J. Endocrinol. 140 (1994), 145–154.
25. Fares, F., Havron, A., Fima, E., Designing a long acting erythropoietin by fusing three carboxyl-terminal peptides of human chorionic gonadotropin beta subunit to the N-terminal and C-terminal coding sequence. Int. J. Cell Biol., 2011, 2011, 275063.
26. Fiddes, J.C., Goodman, H.M., The cDNA for the beta-subunit of human chorionic gonadotropin suggests evolution of a gene by readthrough into the 3'-untranslated region. Nature 286 (1980), 684–687.
27. Fotinou, C., Beauchamp, J., Emsley, P., deHaan, A., Schielen, W.J., Bos, E., Isaacs, N.W., Structure of an Fab fragment against a C-terminal peptide of hCG at 2.0 A resolution. J. Biol. Chem. 273 (1998), 22515–22518.
28. Grenache, D.G., Greene, D.N., Dighe, A.S., Fantz, C.R., Hoefner, D., McCudden, C., Sokoll, L., Wiley, C.L., Gronowski, A.M., Falsely decreased human chorionic gonadotropin (hCG) results due to increased concentrations of the free beta subunit and the beta core fragment in quantitative hCG assays. Clin. Chem. 56 (2010), 1839–1844.
29. Gronowski, A.M., Cervinski, M., Stenman, U.H., Woodworth, A., Ashby, L., Scott, M.G., False-negative results in point-of-care qualitative human chorionic gonadotropin (hCG) devices due to excess hCGbeta core fragment. Clin. Chem. 55 (2009), 1389–1394.
30. Hoermann, R., Spoettl, G., Grossmann, M., Saller, B., Mann, K., Molecular heterogeneity of human chorionic gonadotropin in serum and urine from patients with trophoblastic tumors. Clin. Investig. 71 (1993), 953–960.
31. Hoermann, R., Berger, P., Spoettl, G., Gillesberger, F., Kardana, A., Cole, L.A., Mann, K., Immunological recognition and clinical significance of nicked human chorionic gonadotropin in testicular cancer. Clin. Chem. 40 (1994), 2306–2312.
32. Jackson, A.M., Klonisch, T., Lapthorn, A.J., Berger, P., Isaacs, N.W., Delves, P.J., Lund, T., Roitt, I.M., Identification and selective destruction of shared epitopes in human chorionic gonadotropin beta subunit. J. Reprod. Immunol. 31 (1996), 21–36.
33. Jones, T.A., Zou, J.Y., Cowan, S.W., Kjeldgaard, M., Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47:Pt 2 (1991), 110–119.
34. Kardana, A., Elliott, M.M., Gawinowicz, M.A., Birken, S., Cole, L.A., The heterogeneity of human chorionic gonadotropin (hCG). I. Characterization of peptide heterogeneity in 13 individual preparations of hCG. Endocrinology 129 (1991), 1541–1550.
35. Klonisch, T., Delves, P.J., Berger, P., Panayotou, G., Lapthorn, A.J., Isaacs, N.W., Wick, G., Lund, T., Roitt, I.M., Relative location of epitopes involved in synergistic antibody binding using human chorionic gonadotropin as a model. Eur. J. Immunol. 26 (1996), 1897–1905.
36. Kofler, R., Berger, P., Wick, G., Monoclonal antibodies against human chorionic gonadotropin (hCG): I. Production, specificity, and intramolecular binding sites. Am. J. Reprod. Immunol. 2 (1982), 212–216.
37. Kovalevskaya, G., Birken, S., Kakuma, T., O'Connor, J.F., Early pregnancy human chorionic gonadotropin (hCG) isoforms measured by an immunometric assay for choriocarcinoma-like hCG. J. Endocrinol. 161 (1999), 99–106.
38. Kovalevskaya, G., Birken, S., Kakuma, T., Ozaki, N., Sauer, M., Lindheim, S., Cohen, M., Kelly, A., Schlatterer, J., O'Connor, J.F., Differential expression of human chorionic gonadotropin (hCG) glycosylation isoforms in failing and continuing pregnancies: preliminary characterization of the hyperglycosylated hCG epitope. J. Endocrinol. 172 (2002), 497–506.
39. Kringelum, J.V., Nielsen, M., Padkjaer, S.B., Lund, O., Structural analysis of B-cell epitopes in antibody: protein complexes. Mol. Immunol. 53 (2013), 24–34.
40. Lapthorn, A.J., Harris, D.C., Littlejohn, A., Lustbader, J.W., Canfield, R.E., Machin, K.J., Morgan, F.J., Isaacs, N.W., Crystal structure of human chorionic gonadotropin. Nature 369 (1994), 455–461.
41. Lechner, O., Dirnhofer, S., Gerth, R., Merz, W.E., Wick, G., Berger, P., [Fragments of human chorionic gonadotropin (hCG): diagnosis of pregnancy and tumors]. Wien. Klin. Wochenschr. 107 (1995), 15–19.
42. Lottersberger, C., Hoermann, R., Mann, K., Schwarz, S., Berger, P., Tumor- and pregnancy-derived isoforms of human chorionic gonadotropin: biological and diagnostic relevance. Horm. Res. 59 (2003), 125–134.
43. Lund, H., Paus, E., Berger, P., Stenman, U.-H., Torcellini, T., Halvorsen, T.G., Reubsaet, L., Epitope analysis and, detection of human chorionic gonadotropin (hCG) variants by monoclonal antibodies and mass spectrometry. Tumor Biol. 34 (2014), 1013–1022.
44. Madersbacher, S., Berger, P., Antibodies and immunoassays. Methods 21 (2000), 41–50.
45. Madersbacher, S., Berger, P., Mann, K., Kuzmists, R., Wick, G., Diagnostic value of free subunits of serum chorionic gonadotropin in testicular cancer. Lancet 336 (1990), 630–631.
46. Madersbacher, S., Klieber, R., Mann, K., Marth, C., Tabarelli, M., Wick, G., Berger, P., Free alpha-subunit, free beta-subunit of human chorionic gonadotropin (hCG), and intact hCG in sera of healthy individuals and testicular cancer patients. Clin. Chem. 38 (1992), 370–376.
47. Madersbacher, S., Gerth, R., Mann, K., Dirnhofer, S., Berger, P., Gonadotrophin secretion patterns in testicular cancer patients with greatly increased human chorionic gonadotrophin serum concentrations. J. Endocrinol. 159 (1998), 451–458.
48. Mann, K., Schneider, N., Hoermann, R., Thyrotropic activity of acidic isoelectric variants of human chorionic gonadotropin from trophoblastic tumors. Endocrinology 118 (1986), 1558–1566.
49. Marcillac, I., Troalen, F., Bidart, J.M., Ghillani, P., Ribrag, V., Escudier, B., Malassagne, B., Droz, J.P., Lhomme, C., Rougier, P., et al. Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms. Cancer Res. 52 (1992), 3901–3907.
50. Matzuk, M.M., Hsueh, A.J., Lapolt, P., Tsafriri, A., Keene, J.L., Boime, I., The biological role of the carboxyl-terminal extension of human chorionic gonadotropin [corrected] beta-subunit. Endocrinology 126 (1990), 376–383.
51. McChesney, R., Wilcox, A.J., O'Connor, J.F., Weinberg, C.R., Baird, D.D., Schlatterer, J.P., McConnaughey, D.R., Birken, S., Canfield, R.E., Intact HCG, free HCG beta subunit and HCG beta core fragment: longitudinal patterns in urine during early pregnancy. Hum. Reprod. 20 (2005), 928–935.
52. Merz, W.E., Krause, J.M., Roig, J., Singh, V., Berger, P., Nonassembled human chorionic gonadotropin subunits and {alpha}{alpha}-homodimers use fast-track processing in the secretory pathway in contrast to {alpha}{beta}-heterodimers. Endocrinology 148 (2007), 5831–5841.
53. Novotny, J., Bruccoleri, R., Newell, J., Murphy, D., Haber, E., Karplus, M., Molecular anatomy of the antibody binding site. J. Biol. Chem. 258 (1983), 14433–14437.
54. Novotny, J., Handschumacher, M., Haber, E., Bruccoleri, R.E., Carlson, W.B., Fanning, D.W., Smith, J.A., Rose, G.D., Antigenic determinants in proteins coincide with surface regions accessible to large probes (antibody domains). Proc. Natl. Acad. Sci. U. S. A. 83 (1986), 226–230.
55. O'Connor, J.F., Birken, S., Lustbader, J.W., Krichevsky, A., Chen, Y., Canfield, R.E., Recent advances in the chemistry and immunochemistry of human chorionic gonadotropin: impact on clinical measurements. Endocr. Rev. 15 (1994), 650–683.
56. Pantel, J., Remy, J.J., Salesse, R., Jolivet, A., Bidart, J.M., Unmasking of an immunoreactive site on the alpha subunit of human choriogonadotropin bound to the extracellular domain of its receptor. Biochem. Biophys. Res. Commun. 195 (1993), 588–593.
57. Potterton, E., McNicholas, S., Krissinel, E., Cowtan, K., Noble, M., The CCP4 molecular-graphics project. Acta Crystallogr. D Biol. Crystallogr. 58 (2002), 1955–1957.
58. Schwarz, S., Berger, P., Wick, G., Epitope-selective, monoclonal-antibody-based immunoradiometric assays of predictable specificity for differential measurement of choriogonadotropin and its subunits. Clin. Chem. 31 (1985), 1322–1328.
59. Schwarz, S., Berger, P., Wick, G., The antigenic surface of human chorionic gonadotropin as mapped by murine monoclonal antibodies. Endocrinology 118 (1986), 189–197.
60. Schwarz, S., Krude, H., Klieber, R., Dirnhofer, S., Lottersberger, C., Merz, W.E., Wick, G., Berger, P., Number and topography of epitopes of human chorionic gonadotropin (hCG) are shared by desialylated and deglycosylated hCG. Mol. Cell. Endocrinol. 80 (1991), 33–40.
61. Stenman, U.H., Bidart, J.M., Birken, S., Mann, K., Nisula, B., O'Connor, J., Standardization of protein immunoprocedures. Choriogonadotropin (CG). Scand. J. Clin. Lab. Invest. Suppl. 216 (1993), 42–78.
62. Stenman, U.H., Alfthan, H., Hotakainen, K., Human chorionic gonadotropin in cancer. Clin. Biochem. 37 (2004), 549–561.
63. Stenman, U.H., Tiitinen, A., Alfthan, H., Valmu, L., The classification, functions and clinical use of different isoforms of HCG. Hum. Reprod. Update 12 (2006), 769–784.
64. Sturgeon, C.M., Al-Sadie, R., Annual Review for 2009 – Pregnancy Testing (Urinary hCG). 2010, UK NEQAS for Peptide Hormones, Edinburgh, UK, 1–2.
65. Sturgeon, C.M., Berger, P., Bidart, J.M., Birken, S., Burns, C., Norman, R.J., Stenman, U.H., Differences in recognition of the 1st WHO international reference reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin. Clin. Chem. 55 (2009), 1484–1491.
66. Sturgeon, C.M., Common decision limits – the need for harmonised immunoassays. Clin. Chim. Acta Int. J. Clin. Chem. 432 (2014), 122–126.
67. Surles, M.C., Richardson, J.S., Richardson, D.C., Brooks, F.P. Jr., Sculpting proteins interactively: continual energy minimization embedded in a graphical modeling system. Protein Sci. 3 (1994), 198–210.
68. Tegoni, M., Spinelli, S., Verhoeyen, M., Davis, P., Cambillau, C., Crystal structure of a ternary complex between human chorionic gonadotropin (hCG) and two Fv fragments specific for the alpha and beta-subunits. J. Mol. Biol. 289 (1999), 1375–1385.
69. Toll, H., Berger, P., Hofmann, A., Hildebrandt, A., Oberacher, H., Lenhof, H.P., Huber, C.G., Glycosylation patterns of human chorionic gonadotropin revealed by liquid chromatography-mass spectrometry and bioinformatics. Electrophoresis 27 (2006), 2734–2746.
70. Troalen, F., Bellet, D.H., Ghillani, P., Puisieux, A., Bohuon, C.J., Bidart, J.M., Antigenic determinants on human choriogonadotropin alpha-subunit. II. Immunochemical mapping by a monoclonal antipeptide antibody. J. Biol. Chem. 263 (1988), 10370–10376.
71. Valmu, L., Alfthan, H., Hotakainen, K., Birken, S., Stenman, U.H., Site-specific glycan analysis of human chorionic gonadotropin beta-subunit from malignancies and pregnancy by liquid chromatography–electrospray mass spectrometry. Glycobiology 16 (2006), 1207–1218.
72. Van Regenmortel, M.H., Mapping epitope structure and activity: from one-dimensional prediction to four-dimensional description of antigenic specificity. Methods 9 (1996), 465–472.
73. Van Regenmortel, M.H., What is a B-cell epitope?. Methods Mol. Biol. 524 (2009), 3–20.
74. Wehmann, R.E., Amr, S., Rosa, C., Nisula, B.C., Metabolism, distribution and excretion of purified human chorionic gonadotropin and its subunits in man. Ann. Endocrinol. (Paris) 45 (1984), 291–295.
75. Wide, L., Lee, J.Y., Rasmussen, C., A change in the isoforms of human chorionic gonadotropin occurs around the 13th week of gestation. J. Clin. Endocrinol. Metab. 78 (1994), 1419–1423.
76. Wu, H., Lustbader, J.W., Liu, Y., Canfield, R.E., Hendrickson, W.A., Structure of human chorionic gonadotropin at 2.6 A resolution from MAD analysis of the selenomethionyl protein. Structure 2 (1994), 545–558.